These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24255630)
1. Histologic variations and immunohistochemical features of metastatic clear cell renal cell carcinoma. Lee C; Park JW; Suh JH; Nam KH; Moon KC Korean J Pathol; 2013 Oct; 47(5):426-32. PubMed ID: 24255630 [TBL] [Abstract][Full Text] [Related]
2. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. He H; Zhou GX; Zhou M; Chen L Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394 [TBL] [Abstract][Full Text] [Related]
3. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution. Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401 [TBL] [Abstract][Full Text] [Related]
4. Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohistochemical study. Pires FR; Azevedo RS; Ficarra G; Cardoso AS; Carlos R; Kowalski LP; de Almeida OP Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):e22-7. PubMed ID: 20303042 [TBL] [Abstract][Full Text] [Related]
6. The utility of using immunohistochemistry in the differentiation of metastatic, cutaneous clear cell renal cell carcinoma and clear cell hidradenoma. Velez MJ; Thomas CL; Stratton J; Bergfeld W; Weaver J J Cutan Pathol; 2017 Jul; 44(7):612-615. PubMed ID: 28374447 [TBL] [Abstract][Full Text] [Related]
7. Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma. Aydin H; Young RH; Ronnett BM; Epstein JI Am J Surg Pathol; 2005 Apr; 29(4):520-3. PubMed ID: 15767808 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
10. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients. Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911 [TBL] [Abstract][Full Text] [Related]
11. Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma. Prayson RA; Chamberlain WA; Angelov L Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):422-8. PubMed ID: 20453815 [TBL] [Abstract][Full Text] [Related]
12. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma. Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic study of renal cell carcinoma with rhabdoid features]. Ma J; Zhou XJ; Huang WB; Zhou HB; Jiang SJ; Rao Q; Lu ZF; Shi QL Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):166-70. PubMed ID: 17535682 [TBL] [Abstract][Full Text] [Related]
14. Metastatic renal cell carcinoma involving colon with unusual histologic features and diagnostic challenges: A case report. Saadaat R; Haidary AM; Ibrahimkhil AS; Abdul-Ghafar J Int J Surg Case Rep; 2021 Mar; 80():105627. PubMed ID: 33607369 [TBL] [Abstract][Full Text] [Related]
15. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases. Yu W; Wang Y; Jiang Y; Zhang W; Li Y BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining. Weinbreck N; Marie B; Bressenot A; Montagne K; Joud A; Baumann C; Klein O; Vignaud JM Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143 [TBL] [Abstract][Full Text] [Related]
17. Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy. Wang L; Williamson SR; Wang M; Davidson DD; Zhang S; Baldridge LA; Du X; Cheng L Mol Cancer; 2014 Feb; 13():39. PubMed ID: 24568263 [TBL] [Abstract][Full Text] [Related]
18. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study. Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498 [TBL] [Abstract][Full Text] [Related]
19. The SWI/SNF chromatin-remodeling complex status in renal cell carcinomas with sarcomatoid or rhabdoid features. Kinoshita F; Kohashi K; Sugimoto M; Takamatsu D; Kiyozawa D; Eto M; Oda Y Virchows Arch; 2020 Nov; 477(5):651-660. PubMed ID: 32447490 [TBL] [Abstract][Full Text] [Related]
20. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker. Gokden N; Gokden M; Phan DC; McKenney JK Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]